gener
vaccin
safe
effici
way
protect
human
bodi
specif
pathogen
howev
vaccin
applic
prevent
measur
develop
new
vaccin
slow
expens
process
altern
use
sera
enrich
pathogenspecif
antibodi
suggest
treatment
pathogenspecif
antibodi
could
appli
prophylact
well
therapeut
set
howev
nonhuman
deriv
sera
often
provok
immun
respons
therebi
limit
maximum
number
treatment
possibl
caveat
fact
difficult
obtain
larg
amount
sera
qualiti
risk
contamin
pathogen
particular
virus
limit
human
immunodefici
viru
hiv
hepat
c
viru
hcv
altern
use
monoclon
antibodi
mous
monoclon
antibodi
use
treat
human
limit
success
due
immun
respons
antibodi
provok
alter
approach
could
use
fulli
human
antibodi
novel
technolog
develop
includ
human
mous
antibodi
phage
display
human
b
cell
librari
singl
cell
pcr
technolog
creation
mice
express
human
immunoglobulin
gene
technolog
result
clinic
relev
antibodi
method
directli
tap
potenti
human
immun
system
inde
human
immun
system
safe
assum
best
gener
highli
efficaci
antibodi
antibodi
like
superior
gener
mice
use
phage
display
addit
antibodi
may
better
safeti
profil
antibodi
deriv
mice
novel
technolog
obtain
monoclon
antibodi
human
b
cell
includ
ebv
transform
antibodyproduc
b
cell
activ
singl
cell
pcr
obtain
immunoglobulin
gene
individu
ex
vivo
isol
b
cell
previous
shown
forc
express
human
b
cell
stabl
human
monoclon
antibodi
secret
cell
line
produc
move
describ
ectop
express
constitut
activ
mutant
transcript
factor
signal
transduc
transcript
human
memori
b
cell
result
differenti
block
activ
b
cell
prevent
matur
plasma
cell
transduc
cell
resembl
activ
germin
center
centrocyt
show
enhanc
surviv
expans
present
paper
exploit
enhanc
surviv
expans
human
memori
b
cell
express
activ
form
order
obtain
antigen
specif
immunoglobulin
establish
seri
clone
line
human
b
cell
express
induc
construct
turn
clone
regain
capac
produc
antibodi
allow
identif
clone
produc
specif
antibodi
previous
publish
ectop
express
activ
mutant
human
primari
b
cell
result
block
b
cell
differenti
cell
show
enhanc
surviv
expans
extend
find
show
constitut
activ
b
cell
led
loss
antibodi
surfac
express
cultur
maintain
week
presenc
investig
whether
could
exploit
immort
capac
activ
mutant
order
obtain
human
monoclon
b
cell
line
secret
antigen
specif
antibodi
peripher
blood
memori
b
cell
cultur
presenc
irradi
express
l
cell
cell
interleukin
il
prior
retrovir
transduct
constitut
activ
ca
prestimul
induc
strong
prolifer
result
transduct
effici
follow
transduct
inact
express
chimera
hormonebind
portion
estrogen
receptor
er
therebi
express
cytoplasm
complex
heatshock
protein
incub
tamoxifen
lead
dissoci
heat
shock
protein
constitut
activ
result
receptor
dimer
subsequ
transloc
nucleu
initi
specif
transcript
first
studi
effect
transduc
cell
cultur
tamoxifen
tamoxifen
induc
prolifer
human
primari
b
cell
similar
shown
also
induc
strong
differenti
b
cell
secret
immunoglobulin
level
supernat
b
cell
measur
time
around
week
transduct
level
secret
igg
start
decreas
plu
cultur
cell
figur
also
determin
longterm
effect
constitut
activ
express
igm
secret
igm
express
peripher
blood
b
cell
transduc
cultur
tamoxifen
similar
igg
secret
level
igm
secret
disappear
b
cell
prolong
cultur
figur
declin
immunoglobulin
secret
correspond
declin
surfac
immunoglobulin
express
show
time
constitut
express
human
b
cell
lead
diminish
express
secret
immunoglobulin
question
whether
effect
could
revers
deactiv
constitut
activ
remov
tamoxifen
cultur
cultur
cell
tamoxifen
week
month
immunoglobulin
product
vanish
remov
tamoxifen
cultur
cultur
treat
immunoglobulin
secret
remain
low
absent
figur
treat
igm
igg
immunoglobulin
secret
resum
figur
figur
immunoglobulin
secret
last
day
figur
approxim
day
antibodi
product
came
end
transduc
b
cell
die
shown
previous
induc
differenti
b
cell
plasma
cell
observ
b
cell
activ
togeth
data
support
idea
combin
induc
strong
plasma
cell
differenti
prevent
activ
interestingli
b
cell
line
maintain
capac
secret
immunoglobulin
prolong
cultur
week
month
even
freez
thaw
figur
next
determin
whether
could
obtain
stabl
cell
line
memori
b
cell
isol
clonal
densiti
cultur
isol
memori
b
cell
peripher
blood
two
differ
donor
cultur
cell
cell
plu
hr
transduc
subsequ
cultur
cell
cell
tamoxifen
seven
day
gfppo
b
cell
plate
densiti
cell
per
well
use
high
speed
cell
sort
cultur
cell
tamoxifen
within
two
week
multipl
poli
monoclon
memori
b
cell
clone
expand
frequenc
outgrowth
cell
per
well
cultur
respect
data
show
stabl
memori
b
cell
clone
obtain
clonal
cultur
sinc
transduct
human
b
cell
util
develop
immunoglobulin
produc
b
cell
line
cultur
clonal
densiti
next
step
determin
whether
could
make
antigen
specif
immunoglobulin
produc
b
cell
line
tt
produc
gramposit
bacterium
clostridium
tetani
infant
routin
vaccin
combin
vaccin
diphtheria
pertussi
tetanu
poliomyel
dptp
consequ
adult
memori
b
cell
specif
direct
tt
blood
detect
use
peconjug
recombin
tt
cfragment
rttc
figur
use
flow
cytometri
rttcpo
memori
b
cell
isol
peripher
blood
healthi
donor
cultur
cell
presenc
hr
cell
transduc
cultur
cell
presenc
tamoxifen
seven
day
transduct
cell
check
tt
bind
figur
gfp
sort
maintain
microcultur
cell
per
well
presenc
cell
tamoxifen
within
two
week
number
rttcpo
memori
b
cell
clone
could
select
tabl
expand
next
determin
whether
rttc
sort
cultur
still
capac
produc
immunoglobulin
remov
tamoxifen
cultur
rttc
sort
clone
resum
product
either
igm
igg
figur
c
next
determin
antigen
specif
rttcpo
memori
b
cell
line
major
clone
express
either
igm
igg
specif
tt
determin
igm
igg
specif
tt
elisa
figur
e
togeth
data
show
immort
capac
use
obtain
b
cell
line
capac
secret
antigen
specif
immunoglobulin
mention
also
found
high
number
iga
express
cell
transduc
memori
b
cell
popul
indic
iga
express
cell
transduc
maintain
cultur
like
igg
igm
express
cell
figur
crucial
hallmark
memori
b
cell
cell
undergon
somat
hypermut
affin
matur
mechan
via
becom
abl
develop
high
affin
antibodi
reason
determin
mutat
statu
tt
specif
memori
b
cell
line
one
donor
figur
e
monoclon
memori
b
cell
line
cultur
clonal
densiti
tabl
could
confirm
vdj
sequenc
per
cell
line
one
vdj
sequenc
per
cell
line
detect
figur
one
donor
obtain
three
independ
immunoglobulin
sequenc
one
igg
two
igm
sequenc
figur
interestingli
one
igg
one
igm
similar
basic
pattern
somat
hypermut
igm
sequenc
contain
addit
mutat
one
led
amino
acid
chang
suggest
memori
b
cell
aros
clone
igm
clone
undergon
addit
somat
hypermut
affin
matur
result
present
studi
demonstr
immort
capac
induc
activ
mutant
use
obtain
human
antigenspecif
monoclon
b
cell
line
capac
undergo
plasma
cell
differenti
turn
cell
induc
secret
immunoglobulin
make
use
memori
b
cell
isol
healthi
donor
could
screen
b
cell
posit
select
high
affin
specif
antigen
recent
publish
evid
continu
activ
play
role
lymphomagenesi
classic
hodgkin
lymphoma
show
longterm
cultur
primari
b
cell
express
constitut
activ
mutant
eventu
led
phenotyp
close
resembl
classic
hodgkin
lymphoma
cell
includ
loss
immunoglobulin
express
b
cell
specif
marker
absenc
immunoglobulin
express
import
hallmark
classic
hodgkin
lymphoma
approxim
case
mutat
lead
crippl
immunoglobulin
express
found
howev
major
case
crippl
mutat
found
epigenet
event
promot
region
immunoglobulin
heavi
chain
propos
altern
explan
absenc
immunoglobulin
express
hodgkin
lymphoma
cell
paper
show
inactiv
remov
tamoxifen
cultur
presenc
result
reappear
immunoglobulin
express
although
level
still
rel
low
compar
level
normal
describ
ex
vivo
deriv
plasma
cell
suggest
loss
immunoglobulin
express
primari
b
cell
transduc
depend
activ
found
previous
activ
primari
b
cell
inhibit
express
transcript
factor
crucial
plasma
cell
differenti
postul
inactiv
cell
cultur
lead
reactiv
subsequ
differenti
cell
antibodi
secret
plasma
cell
transduc
b
cell
secret
antibodi
inactiv
presenc
induc
prolifer
plasma
cell
differenti
b
cell
mice
well
human
occur
least
partli
upregul
activ
also
activ
thu
counteract
induc
differenti
activ
transient
hr
compar
day
stimul
lead
antibodi
secret
expect
sinc
cytokin
induc
prolifer
plasma
cell
differenti
b
cell
extend
lifespan
induc
forc
express
induc
mutant
describ
paper
provid
tool
expand
vitro
cultur
singl
human
memori
b
cell
obtain
monoclon
cell
line
howev
cell
line
express
immunoglobulin
induc
activ
mutant
subsequ
inactiv
cell
regain
capac
produc
immunoglobulin
offer
opportun
screen
clone
secret
specif
antibodi
note
antigen
specif
select
function
assay
instead
use
bind
assay
elisa
screen
antitetanu
toxoid
specif
antibodi
describ
previous
howev
tt
specif
antibodi
select
bind
assay
elisa
function
shown
toxin
bind
inhibit
test
tobi
vivo
tt
challeng
model
mice
follow
select
antigenspecif
clone
immunoglobulin
gene
retriev
clone
obviou
next
step
would
scale
product
antibodi
recombin
express
identifi
immunoglobulin
gene
suitabl
cell
line
recombin
antibodi
protein
test
effector
function
like
antigen
depend
cellular
cytotox
adcc
complement
activ
vivo
mice
toxin
inactiv
properti
relev
technolog
present
use
obtain
monoclon
antibodi
antigen
specif
even
present
low
frequenc
human
inde
direct
isol
blood
influenza
virusspecif
b
cell
highli
restrict
b
cell
receptor
repertoir
describ
recent
howev
healthi
volunt
studi
receiv
booster
vaccin
influenza
induc
high
percentag
antibodi
secret
plasma
cell
peripher
blood
individu
inde
abund
antigenspecif
plasma
cell
uniqu
much
often
frequenc
antigen
specif
memori
b
cell
low
exampl
case
appropri
vaccin
induc
overt
antibodi
respons
lack
instanc
method
describ
may
appli
isol
human
antigen
specif
monoclon
antibodi
use
human
materi
approv
medic
ethic
committe
academ
medic
center
univers
amsterdam
project
mec
conting
written
inform
consent
b
cell
obtain
buffi
coat
prepar
peripher
blood
adult
sanquin
amsterdam
netherland
ficol
separ
mac
microbead
describ
manufactur
miltenyi
biotech
macsselect
b
cell
subsequ
sort
ttpo
follow
mab
human
molecul
igg
bdpharmingen
san
diego
ca
ebiosci
iga
f
ab
dako
directli
label
either
fluoroscein
isothiocyan
fitc
phycoerythrin
pe
phycoerythrin
cyanin
allophycocyanin
apc
phycoerythrinindotricarbocyanin
phycoerythrincyanin
allophycocyaninindotricarbocyanin
recombin
tt
cfragment
purchas
boehring
mannheim
mannhein
germani
conjug
pe
cyanotech
corpor
kailakona
hi
previous
describ
stain
cell
sort
use
facsaria
bd
analyz
use
lsrii
bd
flow
cytometri
data
process
flowjo
comput
softwar
treestar
ashland
retrovir
construct
describ
previous
brief
cdna
encod
express
lazaru
lzr
vector
upstream
intern
ribosom
entri
site
ire
marker
gene
signalingincompet
mutant
ngfr
provid
c
bonini
st
raphael
hospit
milan
itali
gfp
allow
independ
translat
product
gene
transduc
target
cell
retrovir
product
phoenix
packag
cell
perform
describ
earlier
b
cell
transduc
retrovirus
activ
cell
presenc
recombin
mous
ngml
r
system
hr
transduct
cell
cultur
presenc
r
system
b
cell
cocultur
gy
mous
l
cell
fibroblast
stabli
express
cell
well
recombin
human
cell
routin
test
pcr
presenc
mycoplasma
ebv
data
shown
plate
coat
antihuman
igg
dako
pb
tetanu
vaccin
dutch
vaccin
institut
netherland
dilut
hr
wash
elisa
wash
buffer
pb
milk
pb
use
block
agent
serial
dilut
cell
cultur
supernat
enzymeconjug
detect
ab
ad
dilut
hrpconjug
antiigg
jackson
immunoresearch
laboratori
ap
conjug
antiigg
dako
tmb
substratestop
solut
biosourc
alkalin
phosphatas
substrat
sigmaaldrich
use
develop
elisa
detect
tetanu
toxin
use
elisa
ridascreen
tetanu
rbiopharm
ag
darmstadt
germani
total
rna
isol
approxim
b
cell
trizol
invitrogen
cdna
gener
subject
pcr
produc
heavi
chain
fragment
use
u
amplitaq
gold
dna
polymeras
appli
biosystem
inc
pcr
product
run
agaros
gel
purifi
clone
ta
clone
vector
accord
manufactur
recommend
invitrogen
sequenc
analysi
perform
use
bigdy
termin
chemistri
appli
biosystem
inc
vectornti
softwar
invitrogen
consensu
sequenc
determin
codon
code
codoncod
corpor
